Local 12: Cervical cancer on the rise among younger patients
Local 12 featured University of Cincinnati Cancer Center patient Jennifer Wesley and physician-researcher Thomas Herzog, MD, to highlight the importance of screenings as cervical cancer is on the rise among younger patients.
A routine screening at Wesley's gynecologist found she had cervical cancer, and Herzog and the Cancer Center team quickly sprung into action to develop a treatment plan. Herzog said recent research has found cervical cancer is on the rise, and in later stages, among young patients.
"That was shocking because we don't see increases in solid tumors, especially in advanced stages, especially considering that this is a disease for which we can easily screen," Herzog, a Cancer Center member, the Paul and Carolyn Flory Professor in Gynecologic Oncology in the UC College of Medicine and director of UC Health’s Gynecologic Cancer Disease Center, told Local 12. "There's no doubt that COVID has had a negative impact on screening."
Wesley is now cancer free and sharing her story that routine screenings saved her life and could save the lives of others as well.
Watch or read the Local 12 story.
Featured photo at top of cervical cancer metastasis courtesy of National Cancer Institute/Winship Cancer Institute of Emory University. Photo taken by Scott Wilkinson and Adam Marcus.
Related Stories
UC experts present neurology research at national conference
April 17, 2026
University of Cincinnati researchers will present abstracts at the 2026 American Academy of Neurology Annual Meeting April 18 to 22 in Chicago.
Health care industry is hiring despite a job market that has cooled
April 16, 2026
The US labor market has cooled but the demand for health care workers, expecially skilled nurses, remains strong. Interviews with UC College of Nursing admininstrators Dr. Donna Green and Dr. Lindsay Davis were part of a WCPO segment on health care industry hiring.
AI advances in the liver disease field
April 15, 2026
MASH represents the advanced inflammatory form of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as nonalcoholic fatty liver disease), where fat accumulation in the liver triggers fibrosis and progressive liver injury. According to a recent MedCentral article, more AI-based clinical assessment tools in MASH are needed.